PMVP

1.29

4.03% 0.05

Handel nachbörslich: 1.24 -0.05 -3.88%

Pmv Pharmaceuticals Inc (PMVP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$1.24

Offen:

$1.24

24-Stunden-Volumen:

529.98K

Relative Volume:

1.72

Marktkapitalisierung:

$68.96M

Einnahmen:

Nettoeinkommen (Verlust:

$-78.34M

KGV:

-0.8705

EPS:

-1.4819

Netto-Cashflow:

$-75.02M

1W Leistung:

+5.74%

1M Leistung:

+10.26%

6M Leistung:

-14.00%

1J Leistung:

-10.42%

1-Tages-Spanne:

$1.24

$1.35

1-Wochen-Bereich:

$1.115

$1.35

52-Wochen-Spanne:

$1.02

$1.88

Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile

Firmenname

Pmv Pharmaceuticals Inc

Sektor

Healthcare (1074)

Branche

Biotechnology (600)

Telefon

(609) 642-6670

Adresse

400 ALEXANDER PARK DRIVE, PRINCETON

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-20

Neueste SEC-Einreichungen

PMVP's Discussions on Twitter

Compare PMVP vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PMVP Pmv Pharmaceuticals Inc	1.29	69.50M	0	-78.34M	-75.02M	-1.4819
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-08	Hochstufung	Oppenheimer	Perform → Outperform
2024-05-13	Eingeleitet	Craig Hallum	Buy
2024-04-12	Eingeleitet	Jefferies	Buy
2023-12-27	Eingeleitet	Ladenburg Thalmann	Buy
2022-03-02	Hochstufung	Oppenheimer	Perform → Outperform
2021-09-22	Hochstufung	Goldman	Neutral → Buy
2021-08-19	Eingeleitet	Oppenheimer	Perform
2021-08-02	Eingeleitet	Guggenheim	Buy
2021-07-29	Eingeleitet	H.C. Wainwright	Buy
2020-10-20	Eingeleitet	BofA Securities	Buy
2020-10-20	Eingeleitet	Cowen	Outperform
2020-10-20	Eingeleitet	Evercore ISI	Outperform
2020-10-20	Eingeleitet	Goldman	Neutral

Alle ansehen

Pmv Pharmaceuticals Inc Aktie (PMVP) Neueste Nachrichten

Aug 21, 2026

ETFs Investing in PMV Pharmaceuticals, Inc. Stocks - TradingView

Aug 21, 2026

Aug 19, 2026

PMV (PMVP) Latest Quarter: The Available Earnings Metric Delivers a Beat in the Latest Reading; Closing Move: The Stock Records a 3.23% Increase on the DayAnalyst Coverage Count - vinanet.vn

Aug 19, 2026

PMV Pharmaceuticals (PMVP) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Aug 19, 2026

Aug 17, 2026

Pmv Pharmaceuticals Inc (NASDAQ: PMVP) Share Price, PMVP Stock News, PMVP Share Price & Updates - Kalkine

Aug 17, 2026

Aug 14, 2026

PMV Pharmaceuticals (NASDAQ:PMVP) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat

Aug 14, 2026

PMV Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet

Aug 14, 2026

Form 8K Pmv Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Canada

Aug 14, 2026

PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights - The Manila Times

Aug 14, 2026

PMV Pharma Reports $18.1 Million Second-Quarter Net Loss - Quiver Quantitative

Aug 14, 2026

PMV Pharmaceuticals (PMVP) flags going-concern risk as rezatapopt advances toward NDA - Stock Titan

Aug 14, 2026

PMVP: Net loss narrowed, but liquidity concerns persist as rezatapopt advances toward NDA submission - TradingView

Aug 14, 2026

Press Release: PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights - Moomoo

Aug 14, 2026

OSTX Stock Price and Chart — AMEX:OSTX - tradingview.com

Aug 14, 2026

Aug 10, 2026